Neutralising injurious stimuli, pro-inflammatory mediator catabolism and polymorphonuclear leukocyte (PMN) clearance are determinants of inflammatory resolution. To this, we recently added innate-type lymphocyte repopulation as being central for restoring post-inflammation tissue homeostasis with a role in controlling innate-immune mediated responses to secondary infection.
INTRODUCTION
Macrophages possess a plasticity of phenotype that explains their protective as well as potentially detrimental role in chronic inflammation and tissue injury 1, 2 . Such heterogeneity arises as macrophages differentiate from monocytes and are exposed to specific tissue and hematopoietic cellderived stimuli. Macrophages are classified as either alternatively or classically activated. The "classical activation" (M1) profile occurs in a type 1 cytokine environment (IFNγ, TNFα) or upon recognition of pathogen-associated molecular patterns 3, 4 . Thus, M1 cells play an important role in protection against pathogens by producing high levels of TNFα, IL-1β, IL-6, IL-12, for instance and low levels of IL-10 and are therefore promoters of Th1-type immune responses 4 . In addition, these cells express high levels of COX 2 and exert anti-proliferative and cytotoxic activities resulting partly from reactive nitrogen and oxygen species including iNOS-derived NO, peroxynitrite, hydrogen peroxide and superoxide 2 . Although such short-term inflammatory activity is beneficial to the host in the terms of combating infection, the persistence of pro-inflammatory processes may results in tissue damage. Therefore, inflammation is counter-balanced by endogenous protective signals including Th2 cytokines (IL-10, IL-4 and IL-13) and apoptotic cells 5 resulting in the development of an antiinflammatory or "alternatively activated" macrophage phenotype 6 . Although exhibiting broad heterogeneity, such M2 cells express mannose receptors and secrete high levels of immunosuppressive IL-10 and TGFβ1 compared to M1 cells 2,6. Innate immune responses are characterised by the initial influx of PMNs followed by monocytederived macrophages leading to resolution followed by injured tissues returning to normal physiology [7] [8] [9] [10] . While a great deal is known about the properties of early-release cytokines and chemokines and their mechanisms of action that drive inflammation, we are still trying to understand
For personal use only. on June 10, 2017. by guest www.bloodjournal.org From more about the soluble mediators and cellular players that trigger resolution and restoration of tissue homeostasis. To this end, we recently identified innate-type lymphocyte repopulation as being central to restoring tissue normal physiology once inflammation resolves with a role in controlling responses to secondary infection 11 . However, given the predominance of macrophages during resolution, the phenotype of these cells is unknown. Therefore, we set about cataloguing the inflammatory status of resolution-phase macrophages and documenting their role in post-inflammation tissue homeostasis. Therefore, a model of self-limiting peritonitis was established from which macrophages could be isolated from its resolution phase. A model of peritonitis that progressed to systemic inflammation was also established for comparison. Using cytokine arrays and proteomic analysis we confirmed that the inflammatory environment macrophages occupied during resolution was anti-inflammatory while the cavity of animals that progressed to systemic inflammation expressed pro-inflammatory cytokines and acute phase proteins. Macrophage phenotyping revealed that while cells from the non-resolving model were M1, resolution-phase macrophages (rM) were alternatively activated but also expressed high levels of COX 2 as well as iNOS, imparting upon them a hybrid phenotype. These macrophages also differed in their abilities to clear bacterial infection with M1 cells being superior to rM cells in this regard. The phenotype of macrophage populations was determined by intracellular cAMP which is elevated in rM and if inhibited transforms their phenotype to that of M1 cells. It transpires that while rM are dispensable for PMN clearance, they signal the repopulation of innate type lymphocytes, one of the critical determinants of successful resolution and tissue homeostasis 11 .
For personal use only. on June 10, 2017. by guest www.bloodjournal.org From 6 w/v SDS, 30% v/v glycerol and 0.002% w/v bromophenol blue in 50 mM Tris-HCl buffer; pH 8.8) was performed in two 15 minute incubations, the first in SDS buffer containing 1% w/v DTT, the second in SDS buffer containing 2.5% w/v iodoacetamide. Electrophoresis in the second dimension was performed after applying the strips to 10% acrylamide gels.
Silver staining and Mass Spectrometry
One-and two-dimensional gels were fixed by overnight incubation in 40% v/v ethanol/10% v/v acetic acid and silver stained using a mass spectrometric compatible protocol 13 . Spots/bands of interest were excised from the gel and underwent reduction by DTT, followed by alkylation with iodoacetamide and dehydration in acetonitrile. The dehydrated gel plugs were rehydrated with 20 ng/µl trypsin (Trypsin Gold; Promega, UK) and incubated overnight at 37°C in a humid chamber.
Trypsin digests were spotted onto a stainless steel target together with matrix (a saturated solution (~10 mg/ml) of α-cyano-4-hydroxycinnamic acid diluted 1:2 in 33% v/v acetonitrile and 0.1% v/v trifluoroacetic acid) and peptide masses were determined by matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) using a Mass Spectrometer (Bruker 7 CA, USA), Ly6G, CD11B, CD11C (both BD Biosciences) or CD3/CD19 (Serotec) using isotype specific antibodies from each respective suppliers and compensated where appropriate for dual labelling. Detection of mannose receptor carried out after cells were permeabilised per manufacturer's instructions using Leukoperm, anti CD206 antibody and isotype control from AbD Serotech (Raleigh, USA). For apoptosis analysis, cells were incubated with ANX V/PI (BD Biosciences).
Cytokine, chemokine, proliferation and cAMP analysis
Cytokines and chemokines were measured by Multiplex cytokine array analysis (Bio-Rad Laboratories Ltd, Hemel Hempstead, UK) using the manufacturers protocols. cAMP was measured by enzyme immunoassay (Cayman Chemicals). To determine whether rM or M1 cells proliferated, BrdU (BD Biosciences) was injected i.p. to mice bearing resolving or non-resolving inflammation 24h after zymosan injection. 3h after BrdU, rM and M1 cells were isolated and BrdU incorporation determined on fixed cells by FACS analysis counter staining with F4/80 to identify macrophage populations using large granular macrophage in the naïve peritoneum as a positive control.
Eicosanoid analysis
Samples stored at -200C were thawed at room temperature and acidified to pH 3. Solid-phase extraction was performed using C18 cartridges and samples analysed for levels of PGD 2 using enzyme immunoassay (Cayman Chemicals).
Bacterial culturing
For personal use only. on June 10, 2017. by guest www.bloodjournal.org From Staphylococcus aureus (serotype V) was grown in Luria Broth and Group B Streptococcus was grown in Bacto Todd Hewitt broth with agitation at 37oC to an OD600 of 0.4; equivalent to 1x108 cfu/ml. Bacteria collected by centrifugation were washed with sterile PBS. For in vivo experiments mice were inoculated intraperitoneally with 3x107 cfu Group B Streptococcus in 300 µl PBS. For in vitro experiments 0.2 x 106 cfu / mL of un-washed S. aureus was used.
In vitro cell stimulation & bacterial killing assay
Peritoneal cells were re-suspended in Dulbecco's modified medium supplemented with 10% foetal bovine serum and 50 µg/ml penicillin and streptomyocin and 0.5 x 10 6 cells per were seeded in well's in a 48 well plate and left to adhere for 1h in a humidified CO2 incubator. After washes, fresh medium was added and the cells were incubated for either 4h or 24h. In some experiments LPS
(PAM-CYS), polyinosine-polycytidylic acid (Poly I:C) or muramyl dipeptide (MDP) (InvivoGen, San Diego, USA) were added to the wells prior to a 20h incubation. In other experiments N6,2′-ODibutyryladenosine 3′,5′-cyclic monophosphate (db-cAMP) or Rp-Adenosine 3′,5′-cyclic monophosphorothioate (rp-cAMP) (Sigma-Aldrich) were added to the wells with or without addition of LPS prior to a 4h incubation. At the end of the incubation, cell-free supernatants were removed and stored in -80 o C until further analysis. To assess macrophage bacterial killing ability, 0.2x10 6 cfu/mL of S. aureus was added to appropriate wells. Plates were centrifuged for 5min at 2000 rpm and incubated for 1h. Subsequent supernatants were subjected to X4 ten-fold dilutions in water prior to dispensing 100µl of the dilutions on to agar plates. The plates were incubated upside down at 37oC
and bacterial colonies were counted 24h later. In some experiments pre-conditioned macrophages from mice injected with rp-cAMP 24h and 16h prior to the experiment were used and further more 
RESULTS

Establishing a model of resolving versus delayed-resolving inflammation
We established a model of resolving peritonitis as well as a more severe model for comparison that progresses to systemic inflammation by injecting 2 distinct quantities of zymosan i.p. into 2 separate groups of mice. Thus, a low dose of 0.1mgs, which triggers a mild and transient inflammation resulting in full recovery and a higher dose of 10mgs that results in a more progressive and prolonged response leading to systemic inflammation was used. The latter affected mice visually including hunching, weight loss and in some cases multiple organ failure consistent with previous publications 15, 16 . Cells were isolated from the inflamed peritoneum of both models and quantified with differential cell counts determined by FACS analysis throughout the response. In low-dose zymosan, PMNs peaked at 8/24h and cleared thereafter with macrophages peaking at 72h and persisting in the peritoneum for up to 3 weeks after stimulation, Figure 1A and B. Populations of macrophages have been found to persist long after apparent resolution in a number of experimental studies (in-house data), the relevance of which to tissue re-modeling and post-resolution restorative physiology is addressed below. By contrast, in response to high-dose zymosan total PMN and macrophages were considerably higher than in the resolving model peaking at 72h, Figure 1A and B.
Analysis of inflammatory exudates revealed elevated levels of pro-inflammatory cytokines and chemokines in exudates of mice that received 10mgs zymosan up to day 9 ( Figure 1C ) and in their plasma at day 16 ( Figure 1D ), indicative of systemic inflammation. In contrast, cell-free inflammatory exudates of resolving inflammation contained predominantly IL-10 and comparatively little pro-inflammatory mediators in their plasma, Figure 1C and D, respectively. Thus, by injecting different levels of an inflammatory irritant we established a model of resolving peritonitis as well as one that progressed to systemic inflammation. As a result, we propose that this self-limiting model (induced by 0.1mg zymosan) be used to identify novel endogenous resolution pathways that may be dysregulated or absent in the delayed or non-resolving inflammation.
Dynamics of monocyte/macrophage trafficking in resolving inflammation
To determine macrophage trafficking in resolving inflammation we characterised the influx of monocytes in response to zymosan (0.1 compared to 10mg) and their cell surface markers as being inflammation rM are derived from a common monocyte precursor that had migrated into the peritoneum by 24h while in non-resolving inflammation there is a more prolonged influx of monocytes over a broader time frame than when inflammation is self-limiting.
Distinct macrophage phenotype in a pro-resolution environment
Using the above models we sought to establish the phenotypes of macrophages taken from a resolving inflammation (0.1mg zymosan) compared to those taken from a non-resolving or proinflammatory environment (10mg zymosan). To this end, macrophages from 72h were isolated and 
Compared to M1, rM cells have reduced bactericidal properties
The role of macrophages during bacterial infections is well documented as is the inhibitory effect that IL-10 has on macrophage bacterial clearance [23] [24] [25] [26] [27] . In agreement with this established paradigm we found that M1 cells from the pro-inflammatory model (10mg zymosan) were more efficient at clearing staphylococcus aureus than rM cells ( Figure 4A ). More importantly, rM's ability to kill bacteria was enhanced by incubation with rp-cAMP (cAMP inhibitor) prior to addition of bacteria.
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Conversely the killing ability of pro-inflammatory macrophages (M1) was reduced by addition of dbcAMP. These findings suggest that modulating macrophage phenotype may alter host ability to combat bacterial infection. To test this in vivo we injected the phosphodiesterase IV inhibitor, theophylline at concentrations that elevate cAMP at 72h to M1-sufficent, pro-inflammatory mice (10mg zymosan). 30mins after theophylline, group B streptococcus was injected i.p. and plasma taken 3h later to determine bacterial load. Theophylline caused an increase in plasma bacterial counts compared to controls and was associated with increased mortality (Figure 4B -C) corroborating in vitro experiments above and showing that converting M1 macrophages to bactericidal-impaired rM allows for enhanced bacterial colonization and mortality concomitant with elevated cAMP, Figure   4D . Equivalent data were obtained with rolipram. The results of these experiments suggest that the phenotypic status of inflammatory macrophages may be a critical determinant of host ability to combat post-inflammation superinfection and that drugs that elevate cAMP may compromise ability of the innate immune response to kill bacteria.
Inflammatory environment dictates macrophage phenotype
We next questioned whether rM cells could alter the course of ongoing inflammation. rM were labeled with PKH26-PCL red and adoptively transferred at 72h to mice bearing a 10mg zymosaninduced (non-resolving) peritonitis with their impact on inflammation determined 24h later.
However, rM cells did not trigger resolution in these animals ( Figure 5A ). Specifically, there was no reduction in total PMNs, macrophages or alterations in lymphocytes numbers (individual cell profile not included). Lymphocytes are pertinent markers of resolution as we have shown recently that lymphocyte repopulation is critical for post-resolution tissue homeostasis 11 . As one explanation for this negative result, transferred PKH26-PCL red -labeled rM, when separated from the non-resolving
For personal use only. on June 10, 2017. by guest www.bloodjournal.org From milieu after 24h using FACSAria were found to synthesise more TNFα than native rM cells with little difference in IL-10, Figure 5B -C. This indicates that despite the robustness of ex vivo stimulation in response to a defined stimulus as shown in Figure 2F -G, the environment of nonresolving inflammation predominated in vivo, transforming rM towards an M1 phenotype. Similar results were obtained when rolipram and theophylline were administered to mice bearing 10mg zymosan where cAMP reduced M1 TNFα but had no effect on leukocyte numbers, supplementary data Figure 8E and F. Thus, while elevating cAMP dampens pro-inflammatory cytokines with implications for resolution of systemic inflammation, it is insufficient to reduce leukocyte numbers in the peritoneum. We suspect that endogenous mediators, specific to ongoing inflammation prevail over pro-resolution signals in terms of regulating cell clearance. Proteomic analysis shed some light on these respective environments finding several acute phase proteins including haptoglobin, hemopexin, pregnancy zone protein and serum amyloid P-component as well as pro-inflammatory HMGB-1 expressed during ongoing inflammation (supplementary data Figure 8A- For
rM mediates post-resolution homeostasis
To gain further insight into the role rM cells play during resolution, macrophages were depleted using clodronate filled liposomes in animals injected with 0.1mg zymosan i.p. Despite macrophages being expectedly reduced by 85% at resolution following clodronate ( Figure 6B ), PMN numbers were also significantly lower in clodronate-treated animals ( Figure 6C ). This was a particularly striking result given that PMN influx in macrophage depleted animals was significantly higher than in controls at onset (4h, Figure 6A ), suggesting that in the presence of limited phagocytosing macrophage numbers, PMNs may be efficiently cleared by stromal cells and/or via lymphatic drainage at resolution. In a recent report we demonstrated the influx of innate type-lymphocytes during inflammatory resolution in rodents and man 11 . These repopulating lymphocytes had no role in actively switching off inflammation (clearing PMN and/or macrophages) but restored tissue homeostasis and controlled against superinfection. In macrophage depleted animals examined here,
we noted significantly fewer repopulating lymphocytes compared to controls at resolution ( Figure   6D ), indicating that one of the functions of rMs during resolution is to trigger lymphocyte repopulation and restore normal physiological function post inflammation. Taking this further, we found that rM COX 2 liberated an arachidonic acid-derived prostanoid that signaled lymphocyte repopulation as administration of a selective COX 2 inhibitor during resolution impaired CD3 cell repopulation, Figure 6E . Moreover, adoptively transferring PKH26-PCL red labelled rM along with equal numbers of PKH2-PCL green labelled M1 cells to a murine peritoneal cavity revealed that after 24h rM cells remained in the peritoneum whereas M1 displayed a greater clearance rate, Figure 6F -G. Given that neither rM nor M1 cells were found to proliferate as determined by BrdU incorporation (data not included), these data suggest that rM cells possess a greater propensity to remain in the peritoneum in order to elicit pro-homeostatic functions via COX 2-derived lipid mediators.
For Indeed, these respective phenotypes were robust in situ and long-lived as rM macrophages from day 6/9 post-resolution cavities continued to elaborate IL-10 and responded ex vivo with quantitatively more IL-10 and COX 2 but not TNFα when treated with defined stimuli (TLR2, TLR4, TLR6 or NOD 2 receptor agonists, the latter is not shown). Therefore, we report these unique cells as being a hybrid of both definitions referring to them as pro-resolution or rM macrophage. Certainly, while macrophage heterogeneity is well recognized to be diverse 2 , the M1/M2 classification has arisen largely from the results of in vitro experiments and it's more likely that macrophage phenotypes 
